Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10756 | 31208147 | Nutrients | Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. | 2019 | Details |
| A10757 | 31208043 | Nutrients | Dietary Fiber in Bilberry Ameliorates Pre-Obesity Events in Rats by Regulating Lipid Depot, Cecal Short-Chain Fatty Acid Formation and Microbiota Composition. | 2019 | Details |
| A10767 | 31203627 | J Agric Food Chem | Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice. | 2019 | Details |
| A10790 | 31191550 | Front Immunol | Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10795 | 31189495 | Clin Nutr | Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. | 2019 | Details |
| A10802 | 31185249 | Cancer Lett | New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. | 2019 | Details |
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10817 | 31175629 | Curr Obes Rep | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. | 2019 | Details |
| A10825 | 31172417 | Hepatol Int | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. | 2019 | Details |
| A10826 | 31171889 | World J Gastroenterol | Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. | 2019 | Details |
| A10827 | 31170503 | Biochim Biophys Acta Mol Cell Biol Lipids | Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10868 | 31149745 | Aliment Pharmacol Ther | Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. | 2019 | Details |
| A10894 | 31136662 | Am J Clin Nutr | Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. | 2019 | Details |
| A10919 | 31124558 | Am J Clin Nutr | Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. | 2019 | Details |
| A10926 | 31119399 | Eur J Nutr | Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature. | 2019 | Details |
| A10927 | 31119300 | Cell Mol Life Sci | Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. | 2019 | Details |
| A10928 | 31117231 | Nutrients | Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation. | 2019 | Details |
| A10936 | 31114130 | World J Gastroenterol | Microbial metabolites in non-alcoholic fatty liver disease. | 2019 | Details |
| A10942 | 31112805 | J Glob Antimicrob Resist | Refractory Helicobacter pylori gastritis: The hidden predictors of resistance. | 2019 | Details |
| A10963 | 31101239 | Arch Med Res | Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10977 | 31094185 | Ter Arkh | Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A10988 | 31089602 | Food Funct | A sulfated polysaccharide from Gracilaria Lemaneiformis regulates cholesterol and bile acid metabolism in high-fat diet mice. | 2019 | Details |
| A11085 | 31050979 | Wiad Lek | Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children. | 2019 | Details |
| A11101 | 31041786 | Semin Liver Dis | Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11103 | 31040626 | Ann Gastroenterol | Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department. | 2019 | Details |
| A11105 | 31040374 | Sci Rep | Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. | 2019 | Details |
| A11110 | 31037218 | J Nutr Sci | Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. | 2019 | Details |
| A11112 | 31036494 | Ann Hepatol | Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). | 2019 | Details |
| A11125 | 31031702 | Front Endocrinol (Lausanne) | The Discovery and Development of Liraglutide and Semaglutide. | 2019 | Details |
| A11131 | 31029645 | Clin Res Hepatol Gastroenterol | Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
| A11187 | 31007175 | Biochim Biophys Acta Mol Basis Dis | Outside the liver box: The gut microbiota as pivotal modulator of liver diseases. | 2018 | Details |
| A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
| A11233 | 30982168 | Obes Surg | Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet. | 2019 | Details |
| A11246 | 30975380 | Prostaglandins Leukot Essent Fatty Acids | Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling. | 2019 | Details |
| A11259 | 30971408 | Dis Model Mech | Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. | 2019 | Details |
| A11280 | 30959577 | Hepatology | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. | 2019 | Details |
| A11291 | 30952918 | Sci Rep | Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11316 | 30942432 | Int J Mol Med | Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non‑alcoholic fatty liver disease mouse model. | 2019 | Details |
| A11322 | 30938723 | Food Funct | Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11329 | 30935932 | Gastrointest Endosc | Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting. | 2019 | Details |
| A11352 | 30926798 | Nat Commun | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11412 | 30905785 | Biochim Biophys Acta Mol Basis Dis | Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. | 2019 | Details |
| A11413 | 30905315 | Adipocyte | Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. | 2019 | Details |
| A11435 | 30896956 | Rev Esp Enferm Dig | An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. | 2019 | Details |
| A11440 | 30894137 | BMC Gastroenterol | The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. | 2019 | Details |
| A11470 | 30882489 | AIDS | Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation. | 2019 | Details |
| A11483 | 30877020 | Pharmacol Ther | Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. | 2019 | Details |
| A11496 | 30871368 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? | 2019 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11523 | 30860608 | Lipids | Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats. | 2019 | Details |
| A11527 | 30856537 | Biomed Pharmacother | Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice. | 2019 | Details |
| A11535 | 30853445 | Transl Res | Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. | 2019 | Details |
| A11551 | 30847736 | Curr Obes Rep | Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. | 2019 | Details |
| A11574 | 30833801 | World J Gastroenterol | Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. | 2019 | Details |
| A11579 | 30832423 | Microorganisms | Microbial Population Changes and Their Relationship with Human Health and Disease. | 2019 | Details |
| A11605 | 30822462 | Prog Lipid Res | Plant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?" | 2019 | Details |
| A11618 | 30818779 | Nutrients | Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. | 2019 | Details |
| A11621 | 30815318 | Food Sci Biotechnol | Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease. | 2018 | Details |
| A11634 | 30810328 | Rev Esp Enferm Dig | An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. | 2019 | Details |
| A11663 | 30798598 | J Agric Food Chem | Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. | 2019 | Details |
| A11666 | 30797009 | Int J Biol Macromol | Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways. | 2019 | Details |
| A11686 | 30791767 | Expert Rev Gastroenterol Hepatol | Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. | 2019 | Details |
| A11695 | 30788772 | J Endocrinol Invest | Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11715 | 30779990 | Clin Gastroenterol Hepatol | Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11736 | 30770929 | Carcinogenesis | MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. | 2020 | Details |
| A11740 | 30770094 | Cell Immunol | Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease. | 2019 | Details |
| A11749 | 30766961 | Hepatol Commun | Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity. | 2018 | Details |
| A11750 | 30766955 | Hepatol Commun | Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine. | 2019 | Details |
| A11761 | 30762938 | Mol Nutr Food Res | Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice. | 2019 | Details |
| A11783 | 30745847 | Int J Biol Sci | Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. | 2019 | Details |
| A11790 | 30744124 | Mar Drugs | Inhibitory Effects of Sodium Alginate on Hepatic Steatosis in Mice Induced by a Methionine- and Choline-deficient Diet. | 2019 | Details |
| A11798 | 30736329 | Nutrients | Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice. | 2019 | Details |
| A11821 | 30720827 | Food Funct | Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet. | 2019 | Details |
| A11822 | 30720188 | Eur Rev Med Pharmacol Sci | Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. | 2019 | Details |
| A11827 | 30719448 | Biomed Res Int | Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11850 | 30708110 | Clin Gastroenterol Hepatol | Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide. | 2019 | Details |
| A11851 | 30708109 | Clin Gastroenterol Hepatol | Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. | 2019 | Details |
| A11857 | 30706694 | J Dig Dis | Role of gut microbial metabolites in nonalcoholic fatty liver disease. | 2019 | Details |
| A11876 | 30700946 | World J Gastroenterol | Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. | 2019 | Details |
| A11894 | 30691143 | Nutrients | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome. | 2019 | Details |
| A11895 | 30690636 | Poult Sci | Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. | 2019 | Details |
| A11897 | 30689995 | Eur J Pharmacol | Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. | 2019 | Details |
| A11912 | 30683985 | Cell Mol Life Sci | The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11922 | 30680920 | Mol Nutr Food Res | Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. | 2019 | Details |
| A11946 | 30671174 | Oxid Med Cell Longev | Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A11947 | 30671129 | Evid Based Complement Alternat Med | Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota. | 2018 | Details |
| A11951 | 30670819 | Nat Rev Endocrinol | Gut microbial metabolites in obesity, NAFLD and T2DM. | 2019 | Details |
| A11974 | 30660825 | Pharmacol Res | Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites. | 2019 | Details |
| A11983 | 30658519 | Int J Mol Sci | Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. | 2019 | Details |
| A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
| A11986 | 30658094 | Pharmacol Res | Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. | 2019 | Details |
| A12002 | 30652107 | Microb Cell | Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD. | 2018 | Details |
| A12006 | 30648978 | Holist Nurs Pract | Traditional Chinese Medicine and Intestinal Microbiota: A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases. | 2020 | Details |
| A12010 | 30646522 | Int J Mol Sci | Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis. | 2019 | Details |